Clinical trial / 2010
Hydrolyzed infant formula reduced beta-cell autoantibodies in children genetically susceptible to diabetes
A randomized controlled trial evaluated 230 infants with genetic susceptibility to type 1 diabetes who received either casein hydrolysate or standard cow's-milk-based formula when breast milk was unavailable during the first 6 to 8 months of life. Over a median 10-year follow-up, infants assigned to casein hydrolysate had a lower risk of developing one or more autoantibodies (unadjusted HR 0.54; 95% CI, 0.29 to 0.95; adjusted HR 0.51; 95% CI, 0.28 to 0.91). Positivity for two or more autoantibodies did not differ significantly between groups.
- Study type
- Randomized controlled trial
- Who was studied
- 230 infants with genetic susceptibility to type 1 diabetes
- What was measured
- Type 1 diabetes-associated autoantibodies
THE PAPER
Dietary intervention in infancy and later signs of beta-cell autoimmunity.
Knip M, Virtanen SM, Seppä K, Ilonen J, Savilahti E, Vaarala O, Reunanen A, Teramo K, Hämäläinen AM, Paronen J, Dosch HM, Hakulinen T, Akerblom HK, Finnish TRIGR Study Group. N Engl J Med, 2010.
This note is written from the study's published abstract. It summarizes what the authors reported; it is not medical advice and does not replace reading the full paper.